Witness History cover image

GLP-1: A breakthrough for diabetes and obesity

Witness History

00:00

Translating discovery into medicines

Svetlana discusses GLP-1's short half-life and her expectation that pharmaceutical companies would develop therapeutic derivatives.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app